Insider Trading & Ownership - Q32 Bio Inc. (QTTB)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Q32 Bio Inc.
Goto Prev, 0, 1, 2, 3
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-01-12
Sale
2021-01-14
4:05 pm
Homology Medicines Inc. FIXX Kelly Timothy P
See Remarks
500 $13 $6,500 45,000
(Direct)
View
2021-01-06
Sale
2021-01-08
4:05 pm
Homology Medicines Inc. FIXX Seymour Albert
Chief Scientific Officer
15,000 $12.06 $180,865 129,017
(Direct)
View
2021-01-05
Sale
2021-01-07
4:05 pm
Homology Medicines Inc. FIXX Seymour Albert
Chief Scientific Officer
10,000 $11.44 $114,422 144,017
(Direct)
View
2021-01-04
Sale
2021-01-06
4:05 pm
Homology Medicines Inc. FIXX Kelly Timothy P
See Remarks
4,000 $11.5 $45,983 81,501
(Direct)
View
2020-12-22
Sale
2020-12-28
9:37 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
500,000 $12.82 $6,410,000 181,435
(Indirect)
View
2020-12-22
Sale
2020-12-28
9:35 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
500,000 $12.82 $6,410,000 181,435
(Indirect)
View
2020-12-14
Sale
2020-12-16
7:25 pm
Homology Medicines Inc. FIXX PARMAR KUSH
Director
500,000 $12.25 $6,125,915 201,435
(Indirect)
View
2020-12-14
Sale
2020-12-16
7:15 pm
Homology Medicines Inc. FIXX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
ROCKLAGE SCOTT M
Schwab Andrew J.
10% Owner
500,000 $12.25 $6,125,915 201,435
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-01-12
Exercise
2021-01-14
4:05 pm
N/A
2027-12-06
Homology Medicines Inc. FIXX Kelly Timothy P
See Remarks
500 $0 45,000
(Direct)
View
2021-01-12
Exercise
2021-01-14
4:05 pm
N/A
N/A
Homology Medicines Inc. FIXX Kelly Timothy P
See Remarks
500 $6.6314 45,000
(Direct)
View
2021-01-04
Exercise
2021-01-06
4:05 pm
N/A
2027-12-06
Homology Medicines Inc. FIXX Kelly Timothy P
See Remarks
4,000 $0 81,501
(Direct)
View
2021-01-04
Exercise
2021-01-06
4:05 pm
N/A
N/A
Homology Medicines Inc. FIXX Kelly Timothy P
See Remarks
2,000 $2.8947 81,501
(Direct)
View
2021-01-04
Exercise
2021-01-06
4:05 pm
N/A
N/A
Homology Medicines Inc. FIXX Kelly Timothy P
See Remarks
2,000 $6.6314 81,501
(Direct)
View
2020-07-21
Option Award
2020-07-21
5:31 pm
N/A
2030-07-20
Homology Medicines Inc. FIXX Poulton Jeffrey V.
Director
36,000 $0 36,000
(Direct)
View
2020-06-10
Option Award
2020-06-12
5:33 pm
N/A
2030-06-10
Homology Medicines Inc. FIXX REICIN ALISE
Director
18,000 $0 18,000
(Direct)
View
2020-06-10
Option Award
2020-06-12
5:31 pm
N/A
2030-06-10
Homology Medicines Inc. FIXX PARMAR KUSH
Director
10% Owner
18,000 $0 18,000
(Direct)
View
2020-06-10
Option Award
2020-06-12
5:27 pm
N/A
2030-06-10
Homology Medicines Inc. FIXX Gregory Richard J.
Director
18,000 $0 18,000
(Direct)
View
2020-06-10
Option Award
2020-06-12
5:27 pm
N/A
2030-06-10
Homology Medicines Inc. FIXX Thistle Mary
Director
18,000 $0 18,000
(Direct)
View
2020-06-10
Option Award
2020-06-12
5:27 pm
N/A
2030-06-10
Homology Medicines Inc. FIXX Patterson Matthew R
Director
18,000 $0 18,000
(Direct)
View
2020-06-10
Option Award
2020-06-12
5:25 pm
N/A
2030-06-10
Homology Medicines Inc. FIXX GILLIS STEVEN
Director
18,000 $0 18,000
(Direct)
View
Goto Prev, 0, 1, 2, 3